Phase III trial comparing the efficacy and safety of recombinant‐ or urine‐derived human chorionic gonadotropin for ovulation triggering in Japanese women diagnosed with anovulation or oligo‐ovulation and undergoing ovulation induction with follitropin‐alfa

AIM: Outside of Japan, recombinant‐human chorionic gonadotropin (r‐hCG) is widely used for the induction of final follicular maturation and early luteinization in women undergoing ovulation induction; whereas in Japan, urine‐derived hCG (u‐hCG) is predominantly used. The primary objective of this st...

Descripción completa

Detalles Bibliográficos
Autores principales: Ikenaga, Hideyuki, Tanaka, Yudai, Shiotani, Masahide, Rogoff, Daniela, Shimizu, Shin, Ishihara, Osamu, Sato, Yoshiaki, Morimoto, Yoshiharu, Fukuda, Aisaku, Aisaka, Kohzo, Yoshida, Koji, Hayashi, Naoki, Oku, Hirotsugu, Abe, Yuji, Haruki, Atsushi, Ishikawa, Motoharu, Kuramoto, Takeshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5715878/
https://www.ncbi.nlm.nih.gov/pubmed/29259450
http://dx.doi.org/10.1002/rmb2.12008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5715878/
https://www.ncbi.nlm.nih.gov/pubmed/29259450
http://dx.doi.org/10.1002/rmb2.12008

Ejemplares similares